Literature DB >> 11839066

Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders.

Andrew Newberg1, Abass Alavi, Martin Reivich.   

Abstract

Functional brain imaging using 18F fluorodeoxyglucose (FDG) and positron emission tomography (PET) has greatly enhanced our understanding of brain function both in normal conditions as well as in a wide variety of neuropsychiatric disorders. We review the uses of FDG PET in the diagnosis, management, and follow-up of patients with neuropsychiatric disorders. This article will also explore what FDG-PET imaging has revealed in these neuropsychiatric disorders and how these findings relate to both research and clinical applications.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11839066     DOI： 10.1053/snuc.2002.29276

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN： 0001-2998            Impact factor:   4.446


  13 in total

1.  No needle to fear: An approach to needle phobic patients.

Authors:  Lauren Hudswell; Joanne Pinson; Shakher Ramdave; Jason Bradley
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

2.  Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy.

Authors:  Ming Lu; Xiao-Hong Zhu; Yi Zhang; Gheorghe Mateescu; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-15       Impact factor: 6.200

Review 3.  Spontaneous neural activity differences in posttraumatic stress disorder: A quantitative resting-state meta-analysis and fMRI validation.

Authors:  Seth G Disner; Craig A Marquardt; Bryon A Mueller; Philip C Burton; Scott R Sponheim
Journal:  Hum Brain Mapp       Date:  2017-11-15       Impact factor: 5.038

Review 4.  The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms.

Authors:  Brian Hung-Hin Lang; Tsz Ting Law
Journal:  Oncologist       Date:  2011-03-04

5.  Rehabilitation of stroke: a new horizon.

Authors:  Brad Steinle; John Corbaley
Journal:  Mo Med       Date:  2011 Jul-Aug

6.  The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma.

Authors:  Brian Hung-Hin Lang
Journal:  J Thyroid Res       Date:  2011-10-09

7.  Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.

Authors:  Abass Alavi; Thomas J Werner; Poul Flemming Høilund-Carlsen; Mona-Elisabeth Revheim
Journal:  Clin Nucl Med       Date:  2022-04-05       Impact factor: 10.782

8.  Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.

Authors:  Baozhong Shen; Tao Huang; Yingying Sun; Zhongnan Jin; Xiao-Feng Li
Journal:  Oncotarget       Date:  2017-06-27

9.  Comparison of EEG microstates with resting state fMRI and FDG-PET measures in the default mode network via simultaneously recorded trimodal (PET/MR/EEG) data.

Authors:  Ravichandran Rajkumar; Ezequiel Farrher; Jörg Mauler; Praveen Sripad; Cláudia Régio Brambilla; Elena Rota Kops; Jürgen Scheins; Jürgen Dammers; Christoph Lerche; Karl-Josef Langen; Hans Herzog; Bharat Biswal; N Jon Shah; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2018-10-27       Impact factor: 5.038

10.  Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain.

Authors:  Sarah L DeVos; Bianca T Corjuc; Derek H Oakley; Chloe K Nobuhara; Riley N Bannon; Alison Chase; Caitlin Commins; Jose A Gonzalez; Patrick M Dooley; Matthew P Frosch; Bradley T Hyman
Journal:  Front Neurosci       Date:  2018-04-24       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.